Author

Philippe Seksik

INFLIXIMAB PLUS AZATHIOPRINE AND QUICK STEROIDS DISCONTINUATION VERSUS AZATHIOPRINE PLUS STEROIDS IN PATIENTS WITH ACUTE SEVERE ULCERATIVE COLITIS RESPONDING TO INTRAVENOUS STEROIDS: A PARALLEL, OPEN-LABEL RANDOMIZED CONTROLLED TRIAL
INFLIXIMAB PLUS AZATHIOPRINE AND QUICK STEROIDS DISCONTINUATION VERSUS AZATHIOPRINE PLUS STEROIDS IN PATIENTS WITH ACUTE SEVERE ULCERATIVE COLITIS RESPONDING TO INTRAVENOUS STEROIDS: A PARALLEL, OPEN-LABEL RANDOMIZED CONTROLLED TRIAL

Philippe Seksik  et al.

COMPARATIVE EFFECTIVENESS OF USTEKINUMAB AND ADALIMUMAB IN THE PREVENTION OF POST-OPERATIVE RECURRENCE IN CROHN’S DISEASE
COMPARATIVE EFFECTIVENESS OF USTEKINUMAB AND ADALIMUMAB IN THE PREVENTION OF POST-OPERATIVE RECURRENCE IN CROHN’S DISEASE

Philippe Seksik  et al.

EARLY INTESTINAL RESECTION IN CROHN’S DISEASE IS NOT ASSOCIATED WITH SEVERE LONG-TERM DISEASE COURSE
EARLY INTESTINAL RESECTION IN CROHN’S DISEASE IS NOT ASSOCIATED WITH SEVERE LONG-TERM DISEASE COURSE

Philippe Seksik  et al.

ENDOSCOPIC SUBMUCOSAL DISSECTION IN INFLAMMATORY BOWEL DISEASE PATIENTS FOR VISIBLE DYSPLASIA: A FRENCH RETROSPECTIVE MULTICENTRIC STUDY
ENDOSCOPIC SUBMUCOSAL DISSECTION IN INFLAMMATORY BOWEL DISEASE PATIENTS FOR VISIBLE DYSPLASIA: A FRENCH RETROSPECTIVE MULTICENTRIC STUDY

Philippe Seksik  et al.

REWIRING THE ALTERED TRYPTOPHAN METABOLISM AS A NOVEL THERAPEUTIC STRATEGY IN INFLAMMATORY BOWEL DISEASES
REWIRING THE ALTERED TRYPTOPHAN METABOLISM AS A NOVEL THERAPEUTIC STRATEGY IN INFLAMMATORY BOWEL DISEASES

Philippe Seksik  et al.

Item 1 - 5 / 5
1